303 related articles for article (PubMed ID: 24387289)
21. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
Kim GA; Han S; Choi GH; Choi J; Lim YS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
[TBL] [Abstract][Full Text] [Related]
23. Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.
Cai S; Yu T; Jiang Y; Zhang Y; Lv F; Peng J
Clin Exp Med; 2016 Aug; 16(3):429-36. PubMed ID: 26164128
[TBL] [Abstract][Full Text] [Related]
24. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
[TBL] [Abstract][Full Text] [Related]
26. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
27. High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
Choi GH; Kim GA; Choi J; Han S; Lim YS
Aliment Pharmacol Ther; 2019 Jul; 50(2):215-226. PubMed ID: 31135074
[TBL] [Abstract][Full Text] [Related]
28. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
29. Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.
McMahon BJ; Bulkow L; Simons B; Zhang Y; Negus S; Homan C; Spradling P; Teshale E; Lau D; Snowball M; Livingston SE
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):701-6.e1-3. PubMed ID: 24035774
[TBL] [Abstract][Full Text] [Related]
30. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
[TBL] [Abstract][Full Text] [Related]
32. Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status.
Nita ME; Gaburo N; Cheinquer H; L'Italien G; Affonso de Araujo ES; Mantilla P; Cure-Bolt N; Lotufo PA
Ann Hepatol; 2009; 8(4):339-45. PubMed ID: 20009133
[TBL] [Abstract][Full Text] [Related]
33. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.
Yuen MF; Yuan HJ; Wong DK; Yuen JC; Wong WM; Chan AO; Wong BC; Lai KC; Lai CL
Gut; 2005 Nov; 54(11):1610-4. PubMed ID: 15871997
[TBL] [Abstract][Full Text] [Related]
34. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Diktas H; Karacaer Z; Özturk II; Cicek H
Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
[TBL] [Abstract][Full Text] [Related]
35. Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT.
Wang CC; Lim LY; Deubner H; Tapia K; Lau AW; Manansala J; Krows M; Shuhart MC; Kowdley KV
J Clin Gastroenterol; 2008 Aug; 42(7):820-6. PubMed ID: 18458642
[TBL] [Abstract][Full Text] [Related]
36. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
[TBL] [Abstract][Full Text] [Related]
37. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
40. [A retrospective study on HBsAg clearance rate after antiviral therapy in children with HBeAg-positive chronic hepatitis B aged 1-7 years].
Zhu SS; Dong Y; Xu ZQ; Wang LM; Chen DW; Gan Y; Wang FC; Yan JG; Cao LL; Wang P; Zhang HF
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):738-743. PubMed ID: 27938558
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]